|
|
|
|
|
|
|
|
|
|
Friday, February 12, 2010
Farletuzumab (MORAb-003) in epithelial ovarian carcinoma; Expert Opinion on Biological Therapy - 10(3):Pages 431-437 - Informa Healthcare
8 comments :
I discovered the basis for FARLETUZUMAB.
ReplyDelete
Please help my rights from the FDA, who is enjoyng it by means of their authority.
Jacob Ghitis, MDPlease post your thougts about FDA's behavior regarding my rights as discoverer of the basis for the first ever treatment of cancer by denying folic acid needed by her accelerated growth: FARLETUZUMAB.
ReplyDelete
You would be helping the victims. Yours,
Jacob Ghitis, MDTo be very frank and honest, I do not have the knowledge nor the background to express a worthwhile opinion. However, at the same time, I do not dismiss your concerns/efforts.
ReplyDeleteThank you Sandi for commenting. If you are still interested, you may google : Jacob Ghitis
ReplyDelete
and also Farletuzumab. More to the point:
"Folic Acid Binder".
Now, you definitely will be interested in knowing that the publication of The Binding of Folate in Milk resulted in the division of the treatment of cancer into two stages: Before, where there was no effective treatment, and After (Now), when there is a physiologically specific treatment. Which is accomplished by limiting the provision to the malignant cells of a very specifically required molecule (a vitamin): Folic Acid. This vitamin plays a multiple role in the growth and development of living cells, by transporting chemical sections required for the completion of molecules. It is quite interesting that this dawn of a new era has not yet comprehended by Humanity.
Jacob Ghitis, MDAll comments require approval to filter out not discussions or opinions but spam such as porn/marketing.
ReplyDelete
Subscribe to:
Post Comments
(
Atom
)
I discovered the basis for FARLETUZUMAB.
ReplyDeletePlease help my rights from the FDA, who is enjoyng it by means of their authority.
Jacob Ghitis, MD
Published litigation??
ReplyDeletePlease post your thougts about FDA's behavior regarding my rights as discoverer of the basis for the first ever treatment of cancer by denying folic acid needed by her accelerated growth: FARLETUZUMAB.
ReplyDeleteYou would be helping the victims. Yours,
Jacob Ghitis, MD
To be very frank and honest, I do not have the knowledge nor the background to express a worthwhile opinion. However, at the same time, I do not dismiss your concerns/efforts.
ReplyDeleteThank you Sandi for commenting. If you are still interested, you may google : Jacob Ghitis
ReplyDeleteand also Farletuzumab. More to the point:
"Folic Acid Binder".
Now, you definitely will be interested in knowing that the publication of The Binding of Folate in Milk resulted in the division of the treatment of cancer into two stages: Before, where there was no effective treatment, and After (Now), when there is a physiologically specific treatment. Which is accomplished by limiting the provision to the malignant cells of a very specifically required molecule (a vitamin): Folic Acid. This vitamin plays a multiple role in the growth and development of living cells, by transporting chemical sections required for the completion of molecules. It is quite interesting that this dawn of a new era has not yet comprehended by Humanity.
Jacob Ghitis, MD
I wrote here my thoughts, but it seems that it has to be approved first. JG
ReplyDeleteAll comments require approval to filter out not discussions or opinions but spam such as porn/marketing.
ReplyDeleteThe is still no interest in helping me on the subject of FARLETUZUMAB!! Jacob Ghitis, MD
ReplyDelete